• OPEN AN ACCOUNT
Indian Indices
Sensex
78,954.76 373.76
( 0.48%)
Global Indices
Nasdaq
54,370.92 264.04
(0.49%)
Dow Jones
7,742.03 -15.49
(-0.20%)
Hang Seng
65,663.80 -636.64
(-0.96%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
21.01
141.85
EPS(TTM)
Face Value()
Div & Yield %
4.24
10
1.35
 

IZMO consolidated net profit rises 151.09% in the March 2026 quarter
May 28,2026
Net profit of IZMO rose 151.09% to Rs 17.30 crore in the quarter ended March 2026 as against Rs 6.89 crore during the previous quarter ended March 2025. Sales rose 82.51% to Rs 109.16 crore in the quarter ended March 2026 as against Rs 59.81 crore during the previous quarter ended March 2025.

For the full year,net profit declined 2.70% to Rs 47.56 crore in the year ended March 2026 as against Rs 48.88 crore during the previous year ended March 2025. Sales rose 26.83% to Rs 284.88 crore in the year ended March 2026 as against Rs 224.61 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales109.1659.81 83 284.88224.61 27
OPM %13.5918.79 -18.2817.05 -
PBDT20.9311.52 82 65.2172.56 -10
PBT16.626.85 143 47.7356.11 -15
NP17.306.89 151 47.5648.88 -3